IME Medical Electrospinning has relocated its R&D and production facility in the Dutch town of Geldrop to a larger facility in Waalre, near Eindhoven in the Netherlands.
The new building will allow the IME Medical Electrospinning to make its electro spinning machines autonomously as well as the actual extracellular matrices or scaffolds that are needed for medical implants, the Waalre, the Netherlands–based company said. The company’s technology solutions replicate natural human extracellular matrix for implants in the human body — with replication taking place down to the nanometer level.
IME Medical Electrospinning plans to officially open the new facility in September of this year.
The Dutch economic development company De Brabantse Ontwikkelings Maatschappij (BOM) and informal investor network TIIN Capital (TIIN) are IME Technologies’ shareholders.